Literature DB >> 12196103

Exoenzyme S binds its cofactor 14-3-3 through a non-phosphorylated motif.

B Hallberg1.   

Abstract

14-3-3 proteins belong to a family of conserved molecules, which play a regulatory role and participate in signal transduction and checkpoint control pathways. 14-3-3 proteins bind phosphoserine-phosphorylated ligands, such as the Raf-1 kinase and Bad, through recognition of the phosphorylated consensus motif, RSXpSXP (where pS is phosphoserine). Recently, a phosphorylation-independent interaction has been reported to occur between 14-3-3 and a small number of proteins, for example the 43 kDa inositol polyphosphate 5-phosphatase, glycoprotein Ib, p75NTR-associated cell-death executor (NADE) and the bacterial ADP-ribosyltransferase toxin exoenzyme S (ExoS). It has been suggested that specific residues of 14-3-3 proteins are required for activation of the bacterial toxin ExoS. An unphosphorylated peptide derived from a phage display library, known as the R18 peptide, and a synthetic peptide derived from ExoS inhibit the interaction between ExoS and 14-3-3. In this report we identify the amino acid sequence on ExoS which is responsible for its specific interaction with 14-3-3, both in vitro and in vivo. In addition, we believe that this interaction is critical for the ADP-ribosylation of an endogenous target, Ras, by ExoS both in vitro and in vivo. Loss of the 14-3-3-binding site on ExoS results in an ExoS molecule that is unable to efficiently inactivate Ras and shows a reduced capacity to change the morphology of infected cells, together with reduced killing activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196103     DOI: 10.1042/bst0300401

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  8 in total

Review 1.  The 14-3-3 proteins: gene, gene expression, and function.

Authors:  Yasuo Takahashi
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

2.  14-3-3eta is a novel regulator of parkin ubiquitin ligase.

Authors:  Shigeto Sato; Tomoki Chiba; Eri Sakata; Koichi Kato; Yoshikuni Mizuno; Nobutaka Hattori; Keiji Tanaka
Journal:  EMBO J       Date:  2005-08-11       Impact factor: 11.598

3.  Microphthalmia-associated transcription factor interactions with 14-3-3 modulate differentiation of committed myeloid precursors.

Authors:  Agnieszka Bronisz; Sudarshana M Sharma; Rong Hu; Jakub Godlewski; Guri Tzivion; Kim C Mansky; Michael C Ostrowski
Journal:  Mol Biol Cell       Date:  2006-07-05       Impact factor: 4.138

4.  Identification of a host 14-3-3 Protein that Interacts with Xanthomonas effector AvrRxv.

Authors:  Maureen Whalen; Todd Richter; Kseniya Zakhareyvich; Masayasu Yoshikawa; Dana Al-Azzeh; Adeshola Adefioye; Greg Spicer; Laura L Mendoza; Christine Q Morales; Vicki Klassen; Gina Perez-Baron; Carole S Toebe; Ageliki Tzovolous; Emily Gerstman; Erika Evans; Cheryl Thompson; Mary Lopez; Pamela C Ronald
Journal:  Physiol Mol Plant Pathol       Date:  2008-01       Impact factor: 2.747

5.  14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.

Authors:  Shaozhong Dong; Sumin Kang; Ting-Lei Gu; Sean Kardar; Haian Fu; Sagar Lonial; Hanna Jean Khoury; Fadlo Khuri; Jing Chen
Journal:  Blood       Date:  2007-03-27       Impact factor: 22.113

6.  Significance of 14-3-3 self-dimerization for phosphorylation-dependent target binding.

Authors:  Ying H Shen; Jakub Godlewski; Agnieszka Bronisz; Jun Zhu; Michael J Comb; Joseph Avruch; Guri Tzivion
Journal:  Mol Biol Cell       Date:  2003-08-07       Impact factor: 4.138

7.  Chimeric 14-3-3 proteins for unraveling interactions with intrinsically disordered partners.

Authors:  Nikolai N Sluchanko; Kristina V Tugaeva; Sandra J Greive; Alfred A Antson
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

8.  Proteomic screen in the simple metazoan Hydra identifies 14-3-3 binding proteins implicated in cellular metabolism, cytoskeletal organisation and Ca2+ signalling.

Authors:  Barbara Pauly; Margherita Lasi; Carol MacKintosh; Nick Morrice; Axel Imhof; Jörg Regula; Stephen Rudd; Charles N David; Angelika Böttger
Journal:  BMC Cell Biol       Date:  2007-07-25       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.